Defining the optimal degree of heparin anticoagulation for peripheral vascular interventions insight from a large, regional, multicenter registry

Christos Kasapis, Hitinder S. Gurm, Stanley J. Chetcuti, Khan Munir, Ann Luciano, Dean Smith, Herbert D. Aronow, Elias H. Kassab, Michael F. Knox, Mauro Moscucci, David Share, P. Michael Grossman

Research output: Contribution to journalArticle

23 Scopus citations

Abstract

Background-The optimal degree of heparin anticoagulation for peripheral vascular interventions (PVIs) has not been defined. We sought to correlate total heparin dose and peak procedural activated clotting time (ACT) with postprocedural outcomes in patients undergoing PVI. Methods and Results-We studied 4743 patients who received heparin during PVIs in a regional, multicenter registry. From those, 1246 had recorded peak procedural ACT with the same point-of-care device. Periprocedural and in-hospital outcomes were compared between patients who received a total heparin dose ≥60 U/kg (n=2161) and ≥60 U/kg (n=2582). Similarly, outcomes were evaluated between groups with a peak procedural ACT ≥250 seconds (n=855) and ≥250 seconds (n=391). Technical and procedural success as well as intraprocedural thrombotic events did not differ between groups. Patients with heparin dose ≥60 U/kg had a higher rate of postprocedural hemoglobin drop ≥3 g/dL (7.09% versus 5.09%, respectively, P<0.004) and a higher transfusion rate compared with those with heparin dose ≥60 U/kg (4.92% versus 3.15%, respectively, P<0.002). In multivariate analysis, independent predictors of bleeding requiring transfusion were total heparin dose ≥60 U/kg, ACT ≥250 seconds, female sex, age ≥70 years, prior anemia, prior heart failure, low creatinine clearance, hybrid vascular surgery, rest pain, and below-knee intervention. In propensity-matched, risk-adjusted models and after hierarchical modeling, total heparin dose ≥60 U/kg and ACT ≥250 seconds remained strong predictors of post-PVI drop in hemoglobin ≥3 g/dL or transfusion. Conclusions-During PVI, higher total heparin dose (≥60 U/kg) and peak ACT ≥250 seconds were predictors of postprocedural transfusion. The high technical and procedural success in all groups suggests that use of weight-based heparin dosing with a target ACT ≥250 seconds in PVI may minimize the bleeding risk without compromising procedural success or increasing thromboembolic complications.

Original languageEnglish (US)
Pages (from-to)593-601
Number of pages9
JournalCirculation: Cardiovascular Interventions
Volume3
Issue number6
DOIs
StatePublished - Dec 1 2010

Keywords

  • Blood coagulation tests
  • Heparin
  • Peripheral interventions
  • Peripheral vascular disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Fingerprint Dive into the research topics of 'Defining the optimal degree of heparin anticoagulation for peripheral vascular interventions insight from a large, regional, multicenter registry'. Together they form a unique fingerprint.

  • Cite this

    Kasapis, C., Gurm, H. S., Chetcuti, S. J., Munir, K., Luciano, A., Smith, D., Aronow, H. D., Kassab, E. H., Knox, M. F., Moscucci, M., Share, D., & Grossman, P. M. (2010). Defining the optimal degree of heparin anticoagulation for peripheral vascular interventions insight from a large, regional, multicenter registry. Circulation: Cardiovascular Interventions, 3(6), 593-601. https://doi.org/10.1161/CIRCINTERVENTIONS.110.957381